KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Assets (2016 - 2025)

Historic Return on Assets for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to 0.5%.

  • Rigel Pharmaceuticals' Return on Assets rose 4800.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year increase of 4800.0%. This contributed to the annual value of 0.12% for FY2024, which is 3200.0% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Return on Assets is 0.5%, which was up 4800.0% from 0.51% recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Return on Assets high stood at 0.51% for Q2 2025, and its period low was 0.68% during Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.11% (2024), whereas its average is 0.13%.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Return on Assets crashed by -6000bps in 2022 and then soared by 6200bps in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Return on Assets (Quarter) stood at 0.1% in 2021, then tumbled by -364bps to 0.47% in 2022, then surged by 54bps to 0.22% in 2023, then soared by 153bps to 0.12% in 2024, then skyrocketed by 338bps to 0.5% in 2025.
  • Its Return on Assets was 0.5% in Q3 2025, compared to 0.51% in Q2 2025 and 0.22% in Q1 2025.